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INTRODUCTION
The epidermal growth factor receptor (EGFR) is an integral
membrane tyrosine kinase that is activated upon binding of a
family of polypeptides that includes epidermal growth
factor (EGF), transforming growth factor-alpha (TGFα),
amphiregulin (AR), heparin-binding EGF (HB-EGF),
betacellulin (BTC), and epiregulin (EPR) (reviewed by Lee et
al., 1995). These ligands share a conserved, three disulfide-
loop structure (the EGF-like motif) that is released by
proteolytic cleavage of transmembrane precursor proteins.
EGFR (erbB1) and its ligands are components of an extended
signaling superfamily that contains three related receptors
(erbB2, erbB3, erbB4) (reviewed by Riese and Stern, 1998),
and multiple additional ligands harboring an EGF-like
sequence (the neuregulins) (Wen et al., 1994; Carraway III et
al., 1997). There is growing evidence, principally from cell
culture, of interactions among superfamily members through
both receptor heterodimerization (reviewed by Heldin, 1995)
and the binding of individual ligands to multiple erbB proteins
(Beerli and Hynes, 1996; Pinkas-Kramarski et al., 1996; Riese
et al., 1996). 
In vitro responses to mammalian EGFR ligands include
altered cell proliferation, differentiation, survival and motility.
However, physiological roles for mammalian EGFR ligands
have not been well defined. As a step toward elucidating these,
we and others have used gene targeting to produce mutant mice
lacking either the EGFR ligand, TGFα, or EGFR itself. Loss
of TGFα produces wavy hair, accompanied by aberrant hair
shaft morphology and deranged follicle patterning (Luetteke et
al., 1993; Mann et al., 1993). It also delays eyelid migration
and fusion in late gestation, predisposing to open eyes at birth
and a spectrum of subsequent eye anomalies (Luetteke et al.,
1993; Mann et al., 1993; Berkowitz et al., 1996). The
characterization of these knockout mice led to the discovery
that the similar phenotypes of spontaneous mouse mutants,
waved-1 (wa-1) and waved-2 (wa-2), are due to reduced
expression of a normal TGFα transcript and a point mutation
in the EGFR tyrosine kinase, respectively (Luetteke et al.,
1994; Fowler et al., 1995; Berkowitz et al., 1996). In addition
to the aforementioned hair and eye abnormalities, ablation of
the mouse EGFR induces peri-implantation through perinatal
death depending on the genetic background of the host mice
(Sibilia and Wagner, 1995; Threadgill et al., 1995; Miettinen
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Targeted mice lacking functional EGF or amphiregulin
(AR) were derived and bred to the TGFα-knockout to
generate mice lacking various combinations of the three
ligands. In contrast to EGF receptor (EGFR) knockout
mice, triple null mice lacking half of the EGFR ligand
family were healthy and fertile, indicative of overlapping
or compensatory functions among EGF family members.
Nevertheless, pups born to triple null dams frequently died
or were runted, suggesting a mammary gland defect.
Comparison of individual and combinatorial knockouts
established that specific loss of AR severely stunted ductal
outgrowth during puberty, consistent with dramatic
expression of AR transcripts in normal developing ducts.
Surprisingly, loss of all three ligands did not significantly
affect cellular proliferation, apoptosis, or ERK activation
within terminal end buds. Following pregnancy, most AR
single null females, but few triple null females could nurse
their young, revealing collaborative roles for EGF and
TGFα in mammopoiesis and lactogenesis. In triple null
glands, alveoli were poorly organized and differentiated,
and milk protein gene expression was decreased.
Additionally, Stat5a activation was frequently reduced in
AR single and combinatorial nulls in association with
impaired lactation. Collectively, our results provide genetic
confirmation of a requirement for EGFR signaling
throughout the development of the mouse mammary gland,
and reveal stage-dependent activities for different EGFR
ligands. Finally, the additional loss of growth factors from
pups nursed by triple null dams further worsened their
survival and growth, establishing functions for both
maternal- and neonatal-derived growth factors.
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et al., 1995). This variable lethality is associated with either
placental defects or impaired epithelial maturation in several
tissues of neonates, including skin, lung and gastrointestinal
tract, indicating that EGFR and its ligands have broad roles in
development.
The rodent mammary gland is one of several epithelial
tissues in which the EGFR system is believed to be crucial.
Experimental evidence includes findings that when EGFR
ligands are exogenously administered by pellet implantation or
ectopically expressed from transgenes, they are potent growth,
differentiation and survival factors for mammary gland
epithelium (reviewed by Schroeder and Lee, 1997).
Additionally, the six EGFR ligands, together with the four erbB
receptors, are all naturally expressed in the mammary gland in
overlapping patterns that nevertheless show some stage- and
cell-type specific distinctions (Schroeder and Lee, 1998).
Moreover, female wa-2 mice harboring the aforementioned
EGFR kinase mutation exhibit deficient lactation as a
consequence of sparse lobuloalveolar development (Fowler et
al., 1995), and ductal outgrowth is retarded in transgenic mice
expressing a truncated, dominant negative form of EGFR (Xie
et al., 1997). Unfortunately, confirmation of these various
results in the EGFR knockout mice has been complicated by
their early lethality.
As a further step toward understanding requirements for the
various EGFR ligands, we have now derived mice that lack
EGF or AR. Additionally, by breeding to our TGFα-null line,
we have also generated the various double and triple null mice
lacking up to half of the EGFR ligand family. Analysis of these
combinatorial mutants confirms the importance of the EGFR
system in both the developing and differentiating mammary
gland. Specifically, the present study reveals a distinct and
essential role for AR in mammary ductal morphogenesis, and
supporting roles for EGF and TGFα in lactogenesis.
MATERIALS AND METHODS
Gene targeting
Genomic clones of the EGF and AR genes were isolated from a
129Sv mouse λ library (Stratagene, La Jolla, CA) by screening with
a 1.9 kb mouse EGF cDNA (a gift from Graeme Bell, Univ. Chicago,
Chicago, IL) or a 0.5 kb PstI-BamHI genomic AR fragment (probe
in Fig. 1A) derived from pMoAR (a gift from Greg Plowman, Sugen,
Redwood City, CA). For the EGF targeting vector, 0.8 kb HincII-
EcoRI and 4.7 kb HindIII-SalI fragments were inserted, respectively,
into the unique BamHI and HindIII sites of pNTK (a gift from
Richard Mortensen, Harvard Medical School, Boston, MA). This
targeting plasmid contains the neomycin resistance and Herpes
Simplex virus thymidine kinase genes driven by the
phosphoglycerate kinase promoter (Mortensen et al., 1992). For the
AR targeting vector, 2.5 kb BamHI-EcoRI and 5.5 kb HindIII
fragments were inserted respectively into the BamHI and HindIII
sites of pNTK. Either E14 or R1 embryonic stem cells were
electroporated with 20 µg of XhoI-linearized EGF or AR constructs
and subjected to positive-negative selection with G418 and
gangcyclovir as previously described (Luetteke et al., 1993). Drug-
resistant ES clones were screened for homologous recombination by
Southern blot analysis of genomic DNAs digested with MscI (EGF)
or XbaI (AR) using 5′ probes from the respective genes (Fig. 1A).
After verification of correct targeting with additional Southern
analyses, ES clones were karyotyped, microinjected into 3.5-day-
old C57BL/6J blastocysts, and implanted into the uterine horns of
pseudopregnant CD-1 foster mothers. Chimeras were crossed to
C57BL/6J partners; thus, subsequent generations of the mice were
on a mixed background of 129 and C57BL/6J strains. 
Tissue harvest and analysis
Mice were killed by CO2 asphyxiation. Six- to twelve-week-old virgin
females were injected with 10 µl/g body weight BrdU (Amersham,
Arlington Heights, IL) 2 hours prior to being killed. The right 3rd
thoracic and 4th inguinal mammary glands were fixed in 10%
formalin for 48-72 hours and processed for paraffin embedding.
Sections (5 µm) prepared by the UNC-CH Histopathology Core Lab
were stained with hematoxylin and eosin or subjected to
immunohistochemistry using alkaline phosphatase-conjugated BrdU
antibody (Cell Proliferation Kit, Boehringer Mannheim, Indianapolis,
IN) or TUNEL assay (Apotag Peroxidase Kit, Oncor, Gaithersburg,
MD). The left 3rd and 4th glands were whole mounted, fixed
overnight in Carnoy’s, and defatted through 3 changes of acetone.
Specimens were rehydrated and stained overnight in 0.2% carmine,
0.5% aluminum potassium sulfate. Slides were dehydrated to absolute
ethanol, cleared in xylene, permanently mounted, and imaged. 
For analyses of pregnant or lactating mammary glands, 5- to 6-
month-old dams were killed, and the extent of epithelial penetration
noted. Third glands were harvested for whole mount and histological
examination as described above. One 4th gland was removed and snap
frozen in liquid nitrogen for total RNA, while the other was
immediately homogenized in lysis buffer (Schroeder and Lee, 1998),
aliquoted, and stored at −80°C. Total protein was assayed using
Coomassie dye (Bio-Rad Laboratories, Hercules, CA). Samples (1
mg) were immunoprecipitated with 1 µg/ml Stat3 or Stat5a antibody
(Santa Cruz, Santa Cruz, CA) and 25 µl protein G agarose (Life
Technologies, Gaithersburg, MD). Immune complexes were washed
three times, denatured and resolved by 10% SDS-PAGE. Gels were
immunoblotted (Schroeder and Lee, 1998) with anti-phosphotyrosine
RC20 (Transduction Laboratories, Lexington, KY). Stripped blots
were reprobed with 0.1 µg/ml anti-Stat3 or Stat5a.
RNA analyses
For northern blots, tissues were homogenized in 4 M guanidinium
isothiocyanate, and total RNA isolated by centrifugation through
CsCl. Samples (10 µg) were electrophoresed through 1.0% agarose
gels containing formaldehyde, and transferred to ZetaProbe (Bio-Rad
Laboratories, Hercules, CA). Immobilized RNA was hybridized with
milk protein cDNAs (kindly provided by Jeffrey Rosen, Baylor
College of Medicine, Houston, TX). RNA loading and integrity were
assessed by comparing ribosomal RNA staining. RT-PCR of AR was
performed (Luetteke et al., 1993) using the following primers: P1: 5′-
ATGAGAACTCCGCTGCTACCGCTG-3′; P4: 5′-ATAACGATGCC-
GATGCCAATAGCT-3′; P5: 5′-ACCCTGCATTGTCCTCAGCTA-3′.
For in situ analyses, 4% paraformaldehyde-fixed, paraffin sections
(10 µm) were deparaffinized, treated for 30 minutes with 10 µg/ml
proteinase K in 0.05 M Tris (pH 8.0), 0.05 M EDTA, acetylated for
10 minutes in 0.1 M triethanolamine (TEA)/0.27% (v/v) acetic
anhydride, and dehydrated through ethanol. Sections were hybridized
with 107 cts/minute of 35S-labeled antisense or sense probe for 18
hours at 54°C in 50% formamide, 2.5× Denhardt’s, 0.6 M NaCl, 10
mM Tris, 1 mM EDTA, 0.1% SDS, 10 mM DTT, 0.5 mg/ml E. coli
tRNA, and 10% dextran sulfate. Following the hybridization, slides
were washed five times for 15 minutes each in 4× SSC at 25°C, treated
with 20 mg/ml RNase A for 30 minutes at 37°C, then washed four
times in 2× SSC/1 mM DTT at 25°C and three times in 0.5× SSC/1
mM DTT at 54°C. Slides were dehydrated in alcohol and exposed to
β-max film (Amersham Life Sciences, Arlington Heights, IL) for 2
days to gauge exposure times. They were then dipped twice in Kodak
NTB2 photo emulsion and stored for 3 days to 4 weeks at 4°C.
Developed slides were stained with hematoxylin and examined by
bright- and dark-field microscopy. The AR probe was a DraII/EcoRV
fragment of the mouse AR cDNA (bases 573-904). The TGFα probe
was described previously (Berkowitz et al., 1996), while the EGF
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probe was an XbaI/PstI fragment (bases 3489-3850) from EGF
cDNA. The EGFR probe was derived from cDNA sequences encoding
the extracellular domain (bases 1552-1857; Luetteke et al., 1994),
while the HB-EGF probe was a 0.4 kb BamHI fragment from exon 2.
Microscopic image analysis was performed with the aid of the UNC-
CH Department of Pathology’s Microscopy Services Laboratory.
RESULTS
Derivation of EGF and AR null mice
To inactivate the mouse EGF and AR genes, targeting vectors
(Fig. 1A) were designed to replace most or all
of the EGF-like motif with the neomycin
resistance cassette. Deletion of EGF exon 20
eliminates the first two disulfide loops, and any
transcriptional readthrough or splicing to exon
21 leads to a frameshift. Deletion of AR exons
3 and 4 eliminates all three disulfide loops
along with the aminoterminal heparin-binding
region and the transmembrane domain of the
precursor, and splicing of exon 2 to exon 5
similarly results in a frameshift. Targeting
constructs were electroporated into E14 (EGF)
or R1 (AR) embryonic stem (ES) cells, and
G418 and gancyclovir-resistant clones screened
by Southern blot. Two of three EGF targeted ES
clones and one of two AR targeted ES clones
microinjected into blastocysts developed into
strong chimeras capable of germline
transmission of the mutant alleles. Intercrosses
of F1 heterozygotes yielded offspring with a
normal Mendelian distribution of genotypes for
EGF (20% EE, 55% Ee, 25% ee) and AR (27%
AA, 50% Aa, 23% aa); the upper and lower case of the first
letter of the growth factor name denote wild-type and mutant
alleles, respectively. Southern blots (not shown) of mouse tail
DNAs verified the expected shifts of diagnostic MscI (EGF)
and XbaI (AR) restriction fragments located within the affected
regions of the genes (Fig. 1A, arrows). 
Northern blots revealed negligible expression of EGF
transcripts in salivary gland and kidney of homozygous
mutants (ee), and western blots failed to detect both the mature
6 kDa species and higher molecular mass forms in salivary




17 18 19 21
Neo







17 18 19 20 21
M M H E H M E
probe 
N N
probe 1 2 3 4 5 6
AR:
1 2
X B H E X B E H









Fig. 1. Targeted inactivation of EGF and AR.
(A) Schematics show wild-type and targeted mouse
EGF and AR alleles with exons numbered (vertical
bars). The 5′ and 3′ regions of homology in the
targeting vectors are indicated by heavy lines, and
dashed lines indicate regions replaced by Neo.
Useful restriction sites are shown, and hatched
boxes depict probes used to confirm homologous
recombination. Arrows indicate diagnostic
restriction fragments. Restriction sites: M, MscI; H,
HindIII; E, EcoRI; N, NcoI; X, XbaI; B, BamHI.
(B) Expression analyses. For EGF, total RNA (20
µg) and protein (200 µg) from adult salivary gland
(SG) and/or kidney (Kid) were subjected to
northern and western blot, respectively, using
cloned cDNA fragments or rabbit anti-mouse EGF
(Upstate Biotechnology Inc., Lake Placid, NY) as
probes. Arrowheads indicate normal transcript (4.8
kb) and mature EGF protein (6 kDa). For AR, the
northern of total RNA from adult stomach and
neonatal skin was hybridized with AR cDNA.
Arrowhead indicates the normal transcript of 1.4 kb.
For RT-PCR, total neonatal skin RNAs were
amplified using primers derived from preserved (P1,
P5) or deleted (P4) AR exons. Products from
indicated primer pairs were Southern blotted with
an exon 3 oligo. Arrowheads denote the wild-type
764 bp (solid) and targeted 400 bp (open) products,
respectively.
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blots of stomach and neonatal skin revealed decreased but
significant levels of a smaller transcript in aa mice. The
residual AR transcript was investigated by RT-PCR using
primers from preserved (P1, P5) or targeted (P4) exons. With
P1/P4 primers, an amplified product of the expected size was
obtained from wild-type but not from aa tissues. In contrast,
primer pair P1/P5, which flanks the deleted exons, yielded
products from both genotypes. However, the product generated
from aa skin (open arrowhead) was smaller and did not
hybridize to an exon 3 probe, consistent with the loss of coding
sequences. Sequence analysis of cloned RT-PCR products
verified that the aa transcript reflected precise splicing of exon
2 to exon 5, predicting a frameshift and premature termination
(data not shown).
EGF and AR null mice displayed no overt phenotype, and
did not exhibit the hair or eye defects observed in TGFα
deficient mice. Moreover, screening of lung, kidney and
gastrointestinal tract did not disclose gross or histological
abnormalities. EGF and AR homozygous mutants were also
fertile, and survival and growth rate of single null pups born
to the respective single null parents were not significantly
different from wild-type values (Table 1). This contrasts with
mild (10%) and severe (50-70%) growth retardation reported,
respectively, in TGFα null (Luetteke et al., 1993) and EGFR
null neonates (Miettinen et al., 1995; Sibilia and Wagner, 1995;
Threadgill et al., 1995).
Triple null mice lacking TGFα, EGF and AR are
viable
The viability and fecundity of the individual knockout lines
allowed us to generate combinatorial knockout mice and
thereby explore possible functional redundancy or
compensation among these EGFR ligands. EGF and TGFα
null mice were mated to obtain double heterozygotes (EeTt),
which were intercrossed to obtain the double homozygotes
(eett). These mice were mated to AR single null mice to derive
triple heterozygotes (AaEeTt). From 68 litters born to AaEeTt
parents, we obtained 5 triple null (aaeett) and 6 wild-type
(AAEETT) pups out of a total of 424 offspring, close to the
fraction (1/64) predicted by Mendelian segregation.
Surprisingly, triple null mice lacking half of the EGFR ligand
family survived to maturity. Consistent with the loss of TGFα,
they exhibited wavy fur and whiskers. In comparison to TGFα
single null mice, they showed an increased penetrance of eye
defects (80-90% versus 40-50%), as well as accelerated hair
and weight loss, dermatitis, and skin ulceration with aging.
Otherwise, aaeett mice displayed no overt phenotype and have
survived for over one year.
AR null virgin females display a mammary gland
phenotype
Matings between double and triple null partners demonstrated
that both sexes of all combinatorial genotypes were fertile.
However, pups born to most double or triple null dams lacking
AR (aaee, aatt, aaeett) often died within 2 days postpartum.
Despite constant nurturing and suckling, these pups had little
or no milk in their stomachs. Perinatal morbidity was most
prevalent among the first litters of mothers between 2-3 months
of age. Nursing competence generally improved with age and
parity, but surviving offspring were usually growth retarded.
These observations suggest that AR deficiency is associated
with impaired mammary gland development and/or function,
N. C. Luetteke and others
Table 1. Birth and growth rates of EGF and AR single null
offspring
Pup body weight (g)
Genotype  Litters Pup survival 1 week old 2 weeks old 3 weeks old
AAEETT 5 31/32 (97%) 4.2±0.14 7.2±0.16 9.1±0.16
AAeeTT 9 62/64 (97%) 3.7±0.08 6.8±0.10 8.0±0.11
aaEETT 8 64/64 (100%) 3.9±0.13 7.0±0.19 9.0±0.24 
Wild-type or targeted partners were mated at 2-3 months of age, and their
offspring counted and weighed weekly until weaning. Genotype refers to both
parents and pups. Data shown is mean body weight and standard error of the
mean.
Fig. 2. Defect in ductal outgrowth in glands from virgin AR null
female mice. Whole mounts of thoracic glands were prepared from
pubescent (A,C,E,G) and mature (B,D,F,H) virgin females of the
indicated genotypes. Note the lack of ductal outgrowth in 6-week-old
(6 wk) AR single and triple null glands. In 12-week-old females,
ductal arborization is complete in wild-type and EGF/TGFα double
null glands, but minimal in AR null glands. Arrowheads indicate
TEBs. m, muscle. Magnification: 10×.
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and potentially aggravated by the additional loss of EGF,
TGFα, or both.
Mammary gland development during puberty is
characterized by progressive outgrowth and branching of a
ductal system throughout the subcutaneous fat pad. This
process is driven by dynamic epithelial structures, denoted
terminal end buds (TEBs), that disappear once the fat pad is
fully arborized. To monitor this stage, we compared whole
mounts of virgin glands of various genotypes. Glands from
pubescent (6 week) AAEETT and Aaeett females displayed
active ductal elongation, led by numerous bulbous TEBs (Fig.
2A,C; arrowheads). In striking contrast, ducts in pubescent
aaEETT and aaeett glands barely extended beyond the
rudimentary anlage, though a few TEBs were visible (Fig.
2E,G; arrowheads). In mature (12 week) virgins, AAEETT and
Aaeett ductal trees completely permeated the fat pads and
lacked TEBs (Fig. 2B,D), but those in aaEETT and aaeett
glands were still underdeveloped and contained persistent
TEBs (Fig. 2F,H; arrowheads). Although their penetration of
the adipose stroma was impeded, ducts in the aaEETT
gland had undergone substantial lateral branching as
evidenced by increased epithelial density (Fig. 2F).
These results demonstrate a specific and unique
requirement for AR during ductal morphogenesis in the
mouse mammary gland. EGF and TGFα are clearly
dispensable for this process, though inspection of
numerous specimens suggested that additional loss of
these ligands may further exacerbate the delay in ductal
outgrowth in the absence of AR (compare Fig. 2F and
H).
Since TEBs formed in AR-deficient mammary
glands, but failed to advance at a normal rate, we
investigated their cellular architecture and activity. AR
and other EGFR ligands promote epithelial cell
proliferation and survival in the mouse mammary gland
(Coleman et al., 1988; Matsui et al, 1990; Sandgren et
al, 1995), and hence we hypothesized that the balance
between DNA synthesis and apoptosis might be altered
in the TEBs of knockout mice. Accordingly, sections of
wild-type and triple null virgin glands were assayed
for BrdU incorporation and terminal deoxytidyl
transferase dUTP nick end labeling (TUNEL) by
immunohistochemistry. Because TEBs were rarely seen
in 6-week-old triple null glands, we compared wild-type
specimens at 6 weeks of age with the persistent TEBs
present in triple null virgins at 6, 8, 10 and 12 weeks of
age. TEBs from both genotypes exhibited the classic
shape and structure, including a leading cap cell layer
(cc), and a dense neck region containing multiple layers
of body cells (bc) trailed by the nascent duct. In glands
of both genotypes, DNA synthesis (BrdU incorporation;
Fig. 3A,B) was prominent in the cap cell layer and outer
body cells, whereas apoptosis (dUTP incorporation;
Fig. 3C,D) was more prevalent in body cells proximal
to the lumen of TEBs (Fig. 3A-D). BrdU labeling
indices in the two genotypes were not significantly
different (20.9±2.3% for AAEETT [13 TEBs, 6-8
weeks]; 21.4±2.4% for aaeett [17 TEBs, 6-12 weeks]),
and were similar to previously reported values
(Humphreys et al., 1996). Apoptosis levels, which
ranged from 3 to 15 percent (average = 7.9±2.7% for
AAEETT TEBs; 7.4±2.8% for aaeett TEBs), were also
comparable between the two genotypes but slightly lower than
the 11% value reported for 5-week-old Balb/c mice
(Humphreys et al., 1996). In accord with normal levels of cell
proliferation and elimination, the mean sizes of TEBs were
nearly identical: 233±27 cells and 234±19 cells for AAEETT
and aaeett glands, respectively. Collectively, these data
unexpectedly indicate that the ductal defect in triple null
females is not due to deregulation of cell growth or death. 
We also examined MAP kinase activation in situ. In TEBs
from both genotypes, dpERK immunostaining was
concentrated in body cells immediately behind the cap cell
layer, and was detected in both cytoplasm and nucleus
consistent with activation-coupled translocation (Fig. 3E,F).
Staining was eliminated when antibody was preincubated with
the dual-phosphorylated peptide antigen, but not
unphosphorylated peptide, confirming specificity (data not
shown). Interestingly, despite frequently scoring positive for
BrdU, cap cells were rarely positive for dpERK, while similar
Fig. 3. DNA synthesis, apoptosis, and ERK activation in TEBs in wild-type
and triple null virgin mammary glands. Immunohistochemistry was performed
on serial sections from 6-week-old wild-type (A,C,E) or 6- to 12-week-old
triple null virgins (8-week old shown; B,D,F) to detect BrdU incorporation
(A,B), dUTP incorporation (TUNEL; C,D), and dual-phosphorylated ERKs
(E,F). Arrowheads and arrows indicate labeled cells undergoing DNA
synthesis and apoptosis, respectively. Mean BrdU labeling indices (± s.e.m.)
were AAEETT, 20.9 ±2.3%; aaeett, 21.4±2.3%. Mean dUTP labeling indices
(± s.e.m.) were AAEETT, 7.9±2.7; aaeett, 7.4±2.8%. cc, cap cells; bc, body
cells. Magnification: 400×.
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regions of body cells stained with both antibodies (compare
Fig. 3A,B to E,F). Anti-dpERK also stained ductal epithelia in
developing glands and periductal stroma in both pubescent and
mature virgin glands (Schroeder and Lee, 1998; data not
shown). Importantly, while there was variation in intensity in
both genotypes, dpERK reactivity of these various cellular
compartments was not appreciably different between wild-type
and triple-null glands. 
AR transcripts are highly expressed during ductal
morphogenesis
Our previous RT-PCR analyses indicated that several EGFR
ligands, including TGFα, BTC, HB-EGF, and AR, are all
expressed in the developing mammary gland, albeit in different
temporal patterns (Schroeder and Lee, 1998). To understand
the unique requirement for AR, we compared expression of AR
and related ligands by in situ hybridization (Fig. 4A). These
analyses revealed dramatic hybridization of AR antisense, but
not sense, probe to sections of 6-week-old wild-type virgin
mammary gland (Fig. 4A; data not shown). Hybridization was
localized in punctate patterns to epithelial cells of ducts and
TEBs. Northern blots revealed temporal regulation of AR
expression with transcripts detected in pubescent but not
mature virgin glands (Fig. 4B). These results are generally
consistent with the previously reported detection of AR
protein, though we did not detect AR transcripts in stroma
(Kenney et al., 1995).
Transcripts for other EGFR ligands were also detected by in
situ hybridization, albeit with much longer exposures (3 weeks
versus 3 days for AR). This suggests that the unique
requirement for AR in ductal morphogenesis may be due in
part to its relatively high level of expression. TGFα and HB-
EGF transcripts were specifically detected in the epithelium of
ducts and TEBs and concentrated near the leading cap cell
layer, though HB-EGF transcripts were also found in stromal
fat (Fig. 4A). In contrast, EGF transcripts were not detected in
either pubescent or mature virgin glands, but were readily
localized to alveolar epithelium in the day 2 lactating gland
(not shown). This matches our previous RT-PCR finding that
EGF expression was uniquely induced during lactogenesis
while expression of the other ligands declined (Schroeder and
Lee, 1998). Finally, receptor transcripts were predominantly
localized to ducts and TEBs of juvenile glands, particularly in
the outermost cell layer of TEBs (Fig. 4A). In agreement with
our previous immunostaining results (Schroeder and Lee,
1998), EGFR expression was also readily observed in
adipocytes (arrowhead) and periductal stroma. Receptor
expression was similarly localized in 10-week-old wild-type
and triple null glands. In the lactating gland, EGFR transcripts
were prevalent in alveolar epithelial cells, but were only
weakly detected in fat (data not shown).
Lobuloalveolar development is abnormal in female
mice lacking AR, EGF, and TGFα
Pregnancy-induced mammopoiesis and lactogenesis are
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Fig. 4. Expression of EGFR and ligands in wild-type mammary glands.
(A) In situ hybridization. Sections from 6-week-old virgin glands were
hybridized to the indicated probes and visualized by either bright-field
(bf) or dark-field (df) microscopy. Results with antisense and sense probes
were compared to confirm specificity of hybridization, but only images
from antisense probes are shown. Exposure times were 10 days for AR or
3 weeks for the others. Note that AR expression was especially strong, but
TGFα, HB-EGF and EGFR transcripts were also prominent in TEBs with
expression concentrated in the outer cell layer (arrow). Additionally, HB-
EGF and EGFR transcripts were detected in fat cells (arrowhead).
Magnification, 200×. (B) Northern blot analysis of AR expression in
pubescent versus mature glands. The two fourth mammary glands of 6-
(n=4) and 10- (n=3) week-old wild-type virgin mice were dissected and
pooled, and total RNA prepared. Samples (10 µg) were electrophoresed,
transferred to membrane, and probed with AR cDNA. The 18S rRNA was
visualized by methylene blue staining to monitor loading and integrity of
RNA. The 1.4 kb AR mRNA is indicated. Numbers above lanes refer to
individual mice.
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characterized by further ductal branching, lobuloalveolar
proliferation and differentiation, and milk production
(reviewed by Hennighausen and Robinson, 1998). To assess
alterations at this stage, whole mounts were prepared from
thoracic glands of 5- to 6-month-old uniparous females at one
day postpartum. Wild-type and EGF/TGFα double null glands
completed lobuloalveolar development, filling the entire fat
pad (Fig. 5A,B). In contrast, single, double and triple null
glands lacking AR displayed only partial penetration of the fat
pad (Fig. 5C-E), consistent with the ductal outgrowth defect in
young virgins. These restricted regions exhibited increased
epithelial density, indicating lobuloalveolar growth had
occurred within the limits of the stunted ductal trees. However,
TEBs, atypical of this stage, often persisted at the periphery of
these areas (Fig. 5C-E; arrowheads). By comparison, lactating
glands from age-matched wa-2 females (Fig. 5F) were fully
traversed by ducts, but had sparser epithelium as previously
reported (Fowler et al., 1995).
Although AR-deficient glands appeared grossly capable of
lobuloalveolar development, conspicuous abnormalities were
evident upon histological evaluation. At day 18 of pregnancy,
control glands contained secretory alveoli engorged with fat
droplets (Fig. 6A). In contrast, alveoli in AR-deficient
glands appeared small, dense, and immature (Fig. 6B-D).
Interestingly, there was a progressive decrease in the
proportion of lipid-laden cells in single (B), double (C), and
triple (D) null specimens, corroborating the notion that
additional loss of the other ligands aggravates the defect in
lobuloalveolar development. On day 2 of lactation, alveoli
in AR-null glands were overcrowded and compressed (Fig.
6E vs 6F,G), consistent with the increased epithelial density
observed in the whole mounts (Fig. 5A vs 5C,D). Compared
to the distended alveoli of normal lactating glands (Fig. 6E),
double (aaee) and triple null specimens (Fig. 6G,H)
exhibited irregular, compact alveolar morphology with
clusters of disorganized or undifferentiated epithelial cells
(arrowhead) interspersed among areas of more synthetic
alveoli resembling those of late pregnancy (Fig. 6G,H vs
6A). Finally, while these alterations were more frequent and
remarkable in AR-deficient glands with minimal ductal
penetration, they were also observed in double and triple
null glands containing substantial (> 50%) ductal outgrowth
(Fig. 6B,C,F-H). This suggests that the delay or defect in
alveolar differentiation was not solely attributable to inferior
ductal morphogenesis. 
Because of the immature appearance of postpartum
knockout glands, we compared expression of milk protein
genes by northern blot. Transcripts for whey acidic protein
(WAP) and β-casein were present at moderate to high levels
in day 2 lactating glands from most genotypes (Fig. 7).
However, WAP and to a lesser extent β-casein transcripts
were variably decreased in AR-deficient glands, especially
those of triple null dams. Not surprisingly, aaeett glands
with minimal ductal outgrowth contained negligible levels
of milk protein mRNA and could not sustain lactation (Fig.
7, asterisks). Importantly, inguinal glands from other triple
null mothers whose pups survived (until day 2) and
displayed 50-80% epithelial penetration, nevertheless had
depressed milk protein gene expression (particularly WAP).
Collectively, these data demonstrate that mammary glands
lacking AR are competent in lobuloalveolar proliferation
and differentiation, but that additional loss of EGF and/or
TGFα compromises lactogenesis. 
The morphology of alveoli and their decreased expression
of WAP are reminiscent of the phenotype of Stat5a knockout
mice (Liu et al., 1997). Normally, activation of Stat5a increases
during lobuloalveolar differentiation, whereas activation of
Stat3 increases during lobuloalveolar involution (Philp et al.,
1996, Liu et al., 1996; Li et al., 1997). Moreover, EGF and AR
stimulate phosphorylation of Stats by the EGFR tyrosine
kinase (David et al., 1996). We therefore assayed activation of
Stats 3 and 5a in day-18-pregnant and day-2-lactating
mammary glands by phosphotyrosine blotting of the
immunoprecipitated proteins. Although levels of Stat5a protein
and activation varied among individual samples, Stat5a
phosphorylation was conspicuously decreased in AR-deficient
glands relative to controls (Fig. 8). Severe reductions were
most prevalent in double and triple null females and correlated
with aberrant morphology and impaired lactation. Stat3
phosphorylation was not observed in the same control or
knockout glands, though the protein was detected (data not
shown). The decrease in Stat5a activation in pregnant AR null
glands, coupled with the uniform absence of Stat3 activation
Fig. 5. Abnormal lobuloalveolar development in lactating glands from AR
null mice. Whole mounts of thoracic glands were prepared from 5- to 6-
month-old uniparous females of the indicated genotypes the day after
parturition. Arrowheads mark boundaries of limited epithelial
development with persistent TEBs. Note the increased epithelial density
in C and D, and decreased epithelial density in F. Magnification: 10×.
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in postpartum glands, indicates immature alveolar
differentiation rather than premature involution. Finally, these
data provide evidence of a physiological relevance for
activation of Stats in response to EGF or AR.
Maternal and neonatal growth factors both influence
pup survival and growth
Surviving pups born to double or triple null parents were
usually growth retarded. This could result from malnutrition
due to the mothers’ impaired mammary gland function and/or
depletion of milk-borne ligands, as well as elimination of
growth factors from the pups themselves. To
evaluate the contribution of neonatal ligands,
we compared the survival and growth of
triple hemizygous versus triple null litters
nursed by triple null mothers. To generate the
requisite litters, we bred 5- to 6-month-old
triple null females, since lactation improved
with aged mothers. Fig. 9 shows that triple
hemizygous pups (AaEeTt) born to triple null
mothers displayed reduced survival (86% vs.
95%) and body weight (70% at 1 week;
compare 1st and 3rd bars) when compared
with wild-type litters born to wild-type
mothers. However, pup survival and growth
rate declined drastically when the pups also
lacked the growth factors. Thus, the survival
of triple null pups reared by triple null
mothers was 25%, and the average weight of
survivors was only 42% of the wild-type
value (compare 1st and 5th bars). For all
groups, similar weight trends were observed
at 2 and 3 weeks of age. We performed a
comparable analysis with aaee double null
mice (2nd and 4th hatched bars of each
weekly set). Again, survival and growth rate
of double hemizygous pups (AaEeTT) born
to aaee double null mothers were moderately
reduced in comparison to wild-type controls,
but were remarkably worse in aaee double
null pups. Further corroboration of the
importance of neonatal growth factors was
obtained from preliminary crossfostering
experiments (not shown). Adopted triple null
pups nursed by wild-type foster mothers
were 15-20% growth-retarded relative to
their wild-type littermates. Collectively,
these results suggest that EGFR ligands
produced both maternally and neonatally
collaborate to ensure the health and growth of
offspring. Removal of both sources of growth
factors, or growth factor responsiveness (i.e.,
the EGFR knockout) severely compromises
perinatal development.
DISCUSSION
EGF family growth factors are hypothesized
to participate in multiple developmental,
physiological and pathological processes,
based on endogenous expression and exogenous effects in
culture systems or animal models. Consistent with a broad
range of ligand activities, ablation of the EGF receptor gene in
mice causes embryonic to perinatal lethality from pleiotropic
abnormalities (Miettinen et al., 1995; Sibilia and Wagner,
1995; Threadgill et al., 1995). Surviving neonates suffer from
hair and eye defects, respiratory distress, growth retardation,
and progressive wasting due to aberrant proliferation and/or
differentiation in epithelia, particularly the skin, lung and
gastrointestinal tract. In light of this severe phenotype, the
viability, fertility, and longevity of our triple null mice (aaeett),
N. C. Luetteke and others
Fig. 6. Morphology of pregnant and lactating mammary glands. Thoracic glands from 5-
to 6-month-old uniparous females of the indicated genotypes were removed the day
before or after parturition, fixed in formalin, sectioned, and stained with hematoxylin and
eosin. Gross estimations of epithelial penetration of the fat pads were (A) 100%, (B) 66%,
(C) 50%, (D) 25%, (E) 100%, (F) 50%, (G) 75%, (H) 66%. For lactation specimens, pup
survival in the respective litters at the time of sacrifice was (E) 5/5, (F) 4/4, (G) 3/7,
(H) 5/5. Note the decreasing accumulation of lipid in alveoli from A to D and the
compact, immature alveolar morphology in F-H. Magnification: 100×.
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lacking half of the known ligand family, is surprising. It also
contrasts with the drastic consequences of mutations in
individual ligands for the Drosophila EGFR (Schweitzer and
Shilo, 1997), suggesting that the mammalian EGF family has
evolved a high degree of functional redundancy or
compensation. In some contexts, this premise is supported by
overlapping spatial and temporal patterns of expression.
Additionally, the natural actions of these growth factors may
be cooperative or cumulative, as evidenced by the aggravation
of ligand-specific problems in the eyes, skin and mammary
glands of our combinatorial mutants. Furthermore, the
potential for EGF family members to activate other erbB
receptors may be relevant to the comparison of phenotypes in
receptor versus ligand knockout mice. The targeted agonists
(AR, EGF, TGFα) only bind EGFR, but induce its
heterodimerization with erbB2 and erbB3 in vitro (Beerli and
Hynes, 1996). The remaining EGFR ligands, betacellulin, HB-
EGF, and epiregulin, also bind erbB4 (Riese et al., 1996;
Elenius, et al., 1997; Riese and Stern, 1998). These intricate
receptor interactions could modify, amplify, or diversify
signaling pathways in vivo, but their physiological significance
has yet to be established.
Our results provide important genetic proof of a need for
EGFR signaling in two stages of mammary gland development.
Furthermore, comparison of our knockouts clearly establishes
that AR is the critical ligand in this tissue. The unique
requirement for AR in ductal morphogenesis could be due to
its intense expression in ducts and TEBs. Additionally, the
potency of AR may differ since it has a lower affinity for the
EGFR than EGF or TGFα (Shoyab et al., 1989). Furthermore,
AR binds heparin, and heparan sulfate proteoglycans modulate
its mitogenic action (Shuger et al., 1996). This potential
regulation of AR availability or activity by extracellular matrix
proteins may be relevant to epithelial-stromal interactions
crucial for ductal outgrowth. Differential proteolytic processing
of the AR precursor could also control its distribution or
presentation to receptors. Finally, AR may evoke distinctive
signaling outputs by favoring association of select erbB receptor
dimers. On the other hand, implantation of pellets containing
AR, EGF, or TGFα initiates ductal outgrowth in virgin glands,
and TGFα appears to be the most potent agonist (Snedeker et
al., 1991; Jones et al., 1996; Kenney et al., 1996). However,
important distinctions in the physiological actions of EGFR
ligands may be masked at pharmacological doses. Whether the
function of these growth factors in the mammary gland arise
from differences in intrinsic expression or bioactivity is being
addressed by knock-in substitution. 
It is intriguing that respective roles for TGFα and AR in hair
follicle and mammary duct morphogenesis similarly involve
penetration of epidermis-derived structures through underlying
adipose tissue, processes dependent on epithelial-
mesenchymal interactions (Hardy, 1992; Cunha and Hom,
1996). Skin graft (Hansen et al., 1997) and mammary gland
transplant experiments (Sebastian et al., 1998; Wiesen et al.,
1999) with EGFR null tissues showed that the receptor is
required in epithelial cells for hair follicle function, but in
stromal cells for ductal outgrowth. In both contexts, the ligands
(TGFα and AR) are expressed in adjacent epithelial cells
suggesting paracrine (or juxtacrine) receptor activation.
Interestingly, ablation of neither growth factor significantly
Fig. 7. Expression of milk protein genes in control
and targeted mice. At day 2 of lactation, inguinal
mammary glands were harvested from uniparous
females of the indicated genotypes, and total RNAs
prepared as described in Materials and Methods.
Samples (10 µg) were analyzed by northern blot for
WAP and β-casein expression using cloned cDNA
probes. Staining of 28S rRNA was used to verify equivalent loading and integrity of RNA. TGFα, EGF or AR genotypes not listed are either
wild type or heterozygous for the targeted allele.
Fig. 8. Activation of Stat5a in mammary glands of
control and AR null mice. At day 18 of pregnancy
or day 2 of lactation, inguinal mammary glands
were harvested from uniparous females of the
indicated genotypes and immediately homogenized
in cold lysis buffer containing protease and
phosphatase inhibitors. Aliquots (1 mg) of total
protein were immunoprecipitated with Stat5a
antibody, resolved on 10% SDS-PAGE, and
immunoblotted with phosphotyrosine antibody
RC20. Blots were stripped and reprobed with the
Stat5a antibody. Exposure times following
chemiluminescent detection were 1 hour for p-Tyr
and 20 seconds for Stat5a.
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affects the proliferation of the cells that produce or respond to
them. Rather, the nature of the AR and TGFα null phenotypes
suggests abnormal epithelial cell migration or adhesion. While
the mechanism by which these ligands mediate these processes
are not understood, candidate signaling pathways include
integrins and their downstream targets (e.g., focal adhesion
kinase and other non-receptor tyrosine kinases). Interactions
between integrins and basement membrane or matrix proteins
influence proliferation, adhesion, and differentiation of
mammary epithelial cells (Streuli and Edwards, 1998) and
α6β4 and laminin are implicated in branching morphogenesis
in culture (Stahl et al., 1997). Since EGFR ligands enhance
phosphorylation or expression of these and other integrin
subunits and thereby stimulate motogenesis (Mainiero et al.,
1996), this could be the mode of AR action. Finally, AR may
also regulate the synthesis or secretion of matrix proteases
necessary for ductal invasion of the stroma (Rudolph-Owen
and Matrisian, 1998; Kondapaka et al., 1997).
Although the impediment in ductal morphogenesis was
the most consistent and distinct mammary phenotype,
lobuloalveolar development was also frequently impaired in
AR-deficient glands, especially in uniparous double or triple
null females. This could reflect a tissue architectural constraint
resulting from inferior ductal outgrowth. However, markers of
differentiation and milk production declined more when EGF
and TGFα were also missing, even in glands with ample ductal
penetration. Thus, further loss of these ligands compounds the
lactation problem. This finding is compatible with the normal
expression of EGF and TGFα and activation of EGFR during
pregnancy and lactation (Schroeder and Lee, 1998). The
precise nature of the EGFR-dependent signal(s) involved in
mammopoiesis and lactogenesis is unknown. Mice
homozygous null for the Stat5a gene, or heterozygous for a
mutant prolactin receptor gene, also failed to lactate following
their first pregnancy due to defective lobuloalveolar
development (Liu et al., 1997; Ormandy et al., 1997). Since
both EGFR ligands and prolactin induce Stat5a
phosphorylation (David et al, 1996), deficiency in the latter
could account for the similar mammary gland defects.
Lobuloalveolar development during pregnancy was also
impaired in cyclin D1 knockout mice (Fantl et al., 1995;
Sicinski et al., 1995), but this phenotype appears to result from
an earlier block in epithelial proliferation rather than
differentiation. The mammary gland phenotype of AR null
mice most closely resembles that of mice lacking the βB
subunit of activins and inhibins, with respect to retarded ductal
elongation, persistent TEBs, deficient alveolar differentiation,
and insufficient lactation (Robinson and Hennighausen, 1997).
Thus, proper development requires a balance or interplay
between both positive and negative regulators produced by
epithelial and stromal cells. Finally, the amelioration of
mammary gland function with increasing age and parity is a
phenomenon also described in the prolactin receptor
heterozygotes (Ormandy et al., 1997) and Stat5a knockouts
(Liu et al., 1998). These observations underscore the adaptive
plasticity of the mammary gland. Perhaps the sensitivity of this
dynamic tissue to multiple growth factors and hormones, many
of which are locally expressed, allows the emergence of
auxillary signaling pathways. 
Our studies also demonstrate the importance of both
maternal and neonatal sources of these growth factors for
optimal pup survival and growth. The growth retardation in
offspring of triple null mothers likely results, in part, from
inadequate quantity or quality of milk, secondary to defective
mammary gland development. However, the remarkable
reduction in survival and body weight when the pups
themselves were also triple null (Fig. 9), coupled with the
runting and wasting of receptor knockout pups (Sibilia and
Wagner, 1995; Threadgill et al., 1995; Miettinen et al., 1995),
supports roles for both endogenous and milk-borne growth
factors in perinatal development. The abundance of EGF in
mouse milk (Beardmore and Richards, 1983; Brown et al.,
1989) has fostered the hypothesis that EGF exerts
cytoprotective or proliferative influences in the gastrointestinal
tract of suckling young (Playford and Wright, 1996). Multiple
EGFR ligands are also expressed in several gastrointestinal
epithelia, albeit at different sites and levels (Barnard et al.,
1995), and may contribute to gut development. Although the
health and growth of EGF single null pups born to EGF single
null mothers casts doubt on some conventional roles ascribed
to this factor, its absence clearly aggravates the lactation
problem in AR null mothers, and worsens survival and growth
rate in their pups. We propose that the poorer prognosis for
double (aaee) or triple null pups born to double or triple null
dams reflects a synergism of disadvantages resulting from
elimination of multiple ligands from multiple sources. Thus,
these neonates would not only be undernourished due to a low
milk supply, but also deprived of maternal and internal growth
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Fig. 9. Influence of maternal and neonatal growth factor deficiency
on pup survival and growth. Wild-type, double-null, and triple null
partners at 5 to 6 months old were mated to generate control or null
neonates as indicated in the accompanying table. Offspring were
weighed at weekly intervals until weaning. Bars show mean body
weight of surviving pups of each neonatal genotype (from each type
of cross) with standard error of the mean shown. Solid bars, pups of
wild-type (AAEETT) mothers; hatched bars, pups of double-null
(aaeeTT) mothers; stippled bars, pups of triple-null (aaeett) mothers.
Note that the last two bars of each weekly set reveal the greatly
reduced (by 50-60%) body weight of double and triple null pups
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factors that may functionally cooperate or compensate for each
other. The availability and viability of the individual and
combinatorial ligand knockouts will facilitate future efforts to
test this notion.
We are grateful to Joyce Schroeder for helpful discussions and
technical assistance in the early phase of this work. We also thank
Greg Plowman for the gift of mouse AR cDNA, Robert Bagnell and
Robert Schoonhoven for assistance with microscopic image analysis,
and Lori Rochelle for advice on in situ hybridization analyses. This
work was supported by NIH grants CA43793 and CA61896 (to D. C.
L.).
REFERENCES
Barnard, J. A., Beauchamp, R. D., Russell, W. E., Dubois, R. N. and
Coffey, R. J. (1995). Epidermal growth factor-related peptides and their
relevance to gastrointestinal pathophysiology. Gastroenterology 108, 564-
580.
Beardmore, J. M. and Richards, R. C. (1983). Concentrations of epidermal
growth factor in mouse milk throughout lactation. J. Endocrinol. 96, 287-
292.
Beerli, R. R. and Hynes, N. E. (1996). Epidermal growth factor-related
peptides activate distinct subsets of erbB receptors and differ in their
biological activities. J. Biol. Chem. 271, 6071-6076.
Berkowitz, E. A., Seroogy, K. B., Schroeder, J. A., Russell, W. E., Evans,
E. P., Riedel, R. F., Phillips, H. K., Harrison, C. A., Lee, D. C. and
Luetteke, N. C. (1996). Characterization of the mouse transforming growth
factor α gene: its expression during eyelid development and in waved-1
tissues. Cell Growth Diff. 7, 1271-1282.
Brown, C. F., Teng, C. T., Pentecost, B. T. and DiAugustine, R. P. (1989).
Epidermal growth factor precursor in mouse lactating mammary gland
alveolar cells. Mol. Endocrinol. 3, 1077-1083.
Carraway III, K. L., Weber, J. L., Unger, M. J., Ledesma, J., Yu, N.,
Gassmann, M. and Lai, C. (1997). Neuregulin-2, a new ligand of
ErbB3/ErbB4-receptor tyrosine kinases. Nature 387, 512-516.
Coleman, S., Silberstein, G. B. and Daniel, C. W. (1988). Ductal
morphogenesis in the mouse mammary gland: evidence supporting a role
for epidermal growth factor. Dev. Biol. 127, 304-315.
Cunha, G. R. and Hom, Y. K. (1996). Role of mesenchymal-epithelial
interactions in mammary development. J. Mam. Gland Biol. Neoplasia 1,
21-35.
David, M., Wong, L., Flavell, R., Thompson, S. A., Wells, A., Larner, A.
C. and Johnson, G. R. (1996). STAT activation by epidermal growth factor
(EGF) and amphiregulin. Requirement for the EGF receptor tyrosine kinase
but not for tyrosine phosphorylation sites or JAK1. J. Biol. Chem. 271, 9185-
9188.
Elenius, K., Paul, S., Allison, G., Sun, J. and Klagsbrun, M. (1997).
Activation of HER4 by heparin-binding EGF-like growth factor stimulates
chemotaxis but not proliferation. EMBO J. 16, 1268-1278.
Fantl, V., Stamp, G., Andrews, A., Rosewell, I. and Dickson, C. (1995).
Mice lacking cyclin D1 are small and show defects in eye and mammary
gland development. Genes Dev. 9, 2364-2372.
Fowler, K. J., Walker, F., Alexander, W., Hibbs, M. L., Nice, E. C., Bohmer,
R. M., Mann, G. B., Thumwood, C., Maglitto, R., Danks, J. A., Chetty,
R., Burgess, A. W. and Dunn A. R. (1995). A mutation in the epidermal
growth factor receptor in waved-2 mice has a profound effect on receptor
biochemistry that results in impaired lactation. Proc. Natl. Acad. Sci. USA
92, 1465-1469.
Hansen, L. A., Alexander, N., Hogan, M. E., Sundberg, J. P., Dlugosz, A.,
Threadgill, D. W., Magnuson, T. and Yuspa, S. H. (1997). Genetically
null mice reveal a central role for epidermal growth factor receptor in the
differentiation of the hair follicle and normal hair development. Am. J.
Pathol. 150, 1959-1975.
Hardy, M. H. (1992). The secret life of the hair follicle. Trends Genet. 8, 55-
61.
Heldin, C.-H. (1995). Dimerization of cell surface receptors in signal
transduction. Cell 80, 213-223.
Hennighausen, L. and Robinson, G. W. (1998). Think globally, act locally:
the making of a mouse mammary gland. Genes Dev.. 12, 449-455.
Humphreys, R. C., Krajewska, M., Krnacik, S., Jaeger, R., Weiher, H.,
Krajewski, S., Reed, J. C. and Rosen, J. M. (1996). Apoptosis in the
terminal endbud of the murine mammary gland: a mechanism of ductal
morphogenesis. Development 122, 4013-4022.
Jones, F. E., Jerry, D. J., Guarino, B. C., Andrews, G. C. and Stern, D. F.
(1996). Heregulin induces in vivo proliferation and differentiation of
mammary epithelium into secretory lobuloalveoli. Cell Growth Diff. 7,
1031-1038.
Kenney, N. J., Huang, R. P., Johnson, G. R., Wu, J. X., Okamura, D.,
Matheny, W., Kordon, E., Gullick, W. J., Plowman, G., Smith, G. H.,
Salomon, D. S. and Adamson E. D. (1995). Detection and location of
amphiregulin and Cripto-1 expression in the developing postnatal mouse
mammary gland. Mol. Reprod. Dev. 41, 277-286.
Kenney, N. J., Smith, G. H., Rosenberg, K., Cutler, M. L. and Dickson, R.
B. (1996). Induction of ductal morphogenesis and lobular hyperplasia by
amphiregulin in the mouse mammary gland. Cell Growth Diff. 7, 1769-1781.
Kondapaka, S. B., Fridman, R. and Reddy, K. B. (1997). Epidermal growth
factor and amphiregulin up-regulate matrix matalloproteinase-9 (MMP-9)
in human breast cancer cells. Int. J. Cancer 7, 722-726. 
Lee, D. C., Fenton, S. E., Berkowitz, E. A. and Hissong, M. A. (1995).
Transforming growth factor-α: expression, regulation, and biological
activities. Pharm. Rev. 47, 51-85.
Li, M., Liu, X., Robinson, G., Bar-Peled, U., Wagner, K- U., Young, W. S.,
Hennighausen, L. and Furth, P. A. (1997). Mammary-derived signals
activate programmed cell death during the first stage of mammary gland
involution. Proc. Natl. Acad. Sci. USA 94, 3425-3430.
Liu, X., Robinson, G. W. and Hennighausen, L. (1996). Activation of Stat5a
and Stat5b by tyrosine phosphorylation is tightly linked to mammary gland
differentiation. Mol. Endocrinol. 10, 1496-1506.
Liu, X., Robinson, G. W., Wagner, K.-U., Garrett, L., Wynshaw-Boris, A.
and Hennighausen, L.. (1997). Stat5a is mandatory for adult mammary
gland development and lactogenesis. Genes Dev. 11, 179-186.
Liu, X., Gallego, M. I., Smith, G. H., Robinson, G. W. and Hennighausen,
L. (1998). Functional rescue of Stat5a-null mammary tissue through the
activation of compensating signals including Stat 5b. Cell Growth Diff. 9,
795-803.
Luetteke, N. C., Qiu, T. H., Peiffer, R. L., Oliver, P., Smithies, O. and Lee,
D.C. (1993). TGFα deficiency results in hair follicle and eye abnormalities
in targeted and waved-1 mice. Cell 73, 263-278.
Luetteke, N. C., Phillips, H. K., Qiu, T. H., Copeland, N. G., Earp, H. S.,
Jenkins, N.A. and Lee, D. C. (1994). The mouse waved-2 phenotype results
from a point mutation in the EGF receptor tyrosine kinase. Genes Dev. 8,
399-413.
Mainiero, F., Pepe, A., Yeon, M., Ren, Y. and Giancotti, F. G. (1996). The
intracellular functions of α6β4 integrin are regulated by EGF. J. Cell Biol.
134, 241-253.
Mann, G. B., Fowler, K. J., Gabriel, A., Nice, E. C., Williams, R. L. and
Dunn, A. R. (1993). Mice with a null mutation of the TGF-α gene have
abnormal skin architecture, wavy hair, and curly whiskers and often develop
corneal inflammation. Cell 73, 249-261.
Matsui, Y., Halter, S. A., Holt, J. T., Hogan, B. L. M. and Coffey, R. J.
(1990). Development of mammary hyperplasia and neoplasia in MMTV-
TGFα transgenic mice. Cell 61, 1147-1155.
Miettinen, P. J., Berger, J. E., Meneses, J., Phung, Y., Pedersen, R. A.,
Werb, Z. and Derynck R. (1995). Epithelial immaturity and multiorgan
failure in mice lacking epidermal growth factor receptor. Nature 376, 337-
341.
Mortensen, R. M., Conner, D. A., Chao, S., Geisterfer-Lowrance, A. A. T.
and Seidman, J. G. (1992). Production of homozygous mutant ES cells
with a single targeting construct. Mol. Cell. Biol. 12, 2391-2395.
Ormandy, C. J., Camus, A., Barra, J., Damotte, D., Lucas, B., Buteau, H.,
Edery, M., Brousse, N., Babinet, C., Binart, N. and Kelly, P. A. (1997).
Null mutation of the prolactin receptor gene produces multiple reproductive
defects in the mouse. Genes Dev. 11, 167-178.
Philp, J. A. C., Burdon, T. G. and Watson, C. J. (1996). Differential
activation of Stats 3 and 5 during mammary gland development. FEBS Lett.
396, 77-80.
Pinkas-Kramarski, R., Shelly, M., Glathe, S., Ratzkins, B. J. and Yarden,
Y. (1996). Neu differentiation factor/neuregulin isoforms activate distinct
receptor combinations. J. Biol. Chem. 271, 19029-19032.
Playford, R. J. and Wright, N. A. (1996). Why is epidermal growth factor
present in the gut lumen? Gut 38, 303-305.
Riese, D. J., Bermingham, Y., Raaij, T. M. V., Buckley, S., Plowman, G. D.
and Stern, D. F. (1996). Betacellulin activates the epidermal growth factor
receptor and erbB4, and induces cellular response patterns distinct from
2750
those stimulated by epidermal growth factor or neuregulin-β. Oncogene 12,
345-353.
Riese, D. J. and Stern, D. F. (1998). Specificity within the EGF family/ErbB
receptor family signaling network. BioEssays 20, 41-48.
Robinson, G. W. and Hennighausen, L. (1997). Inhibins and activins
regulate mammary epithelial cell differentiation through mesenchymal-
epithelial interactions. Development 124, 2701-2708.
Rudolph-Owen, L. A. and Matrisian, L. M. (1998). Matrix
metalloproteinases in remodeling of the normal and neoplastic mammary
gland. J. Mam. Gland Develop. Neoplasia 2, 177-190.
Sandgren, E. P., Schroeder, J. A. Qiu, T. H. Palmiter, R. D. Brinster, R. L.
and Lee, D. C. (1995). Inhibition of mammary gland involution is
associated with transforming growth factor a but not c-myc-induced
tumorigenesis in transgenic mice. Cancer Res. 55, 3915-3927.
Schroeder, J. A. and Lee, D. C. (1997). Transgenic mice reveal roles for
TGFα and EGF receptor in mammary gland development and neoplasia. J.
Mam. Gland Biol. Neoplasia 2, 119-129.
Schroeder, J. A. and Lee, D. C. (1998). Dynamic expression and activation
of ERBB receptors in the developing mouse mammary gland. Cell Growth
Diff. 9, 451-464.
Schweitzer, R. and Shilo, B.-Z. (1997). A thousand and one roles for the
Drosophila EGF receptor. Trends Genet. 13, 191-196.
Sebastian, J., Richards, R. G., Walker, M. P., Wiesen, J. F., Werb, Z.,
Derynck, R., Hom, Y. K., Cunha, G. R. and DiAugustine R. P. (1998).
Activation and function of the epidermal growth factor receptor and erbB2
during mammary gland morphogenesis. Cell Growth Diff. 9, 777-785. 
Shoyab, M., Plowman, G. D., McDonald, V. L., Bradley, J. G. and Todaro,
G. J. (1989). Structure and function of human amphiregulin: a member of
the epidermal growth factor family. Science 243, 1074-1076.
Shuger, L., Johnson, G. R., Gilbride, K., Plowman, G.D. and Mandel, R.
(1996). Amphiregulin in lung branching morphogenesis: interaction with
heparan sulfate proteoglycan modulates cell proliferation. Development 122,
1759-1767.
Sibilia, M. and Wagner, E. F. (1995). Strain-dependent epithelial defects in
mice lacking the EGF receptor. Science 269, 234-238.
Sicinski, P., Donaher, J. L., Parker, S. B., Li, T., Fazeli, A., Gardner, H.,
Haslam, S. Z., Bronson, R. T., Elledge, S. J. and Weinberg, R. A. (1995).
Cyclin D1 provides a link between development and oncogenesis in the
retina and breast. Cell 82, 621-630.
Snedeker, S. M., Brown, C. F. and DiAugustine, R. P. (1991). Expression
and functional properties of transforming growth factor α and epidermal
growth factor during mouse mammary gland ductal morphogenesis. Proc.
Natl. Acad. Sci. 88, 276-280.
Stahl, S., Weitzman, S. and Jones, J. C. R. (1997). The role of laminin-5
and its receptors in mammary epithelial cell branching morphogenesis. J.
Cell Sci. 110, 55-63.
Streuli, C. H. and Edwards, G. M. (1998). Control of normal mammary
epithelial phenotype by integrins. J. Mam. Gland Biol. Neoplasia 3, 151-
164.
Threadgill, D. W., Dlgosz, A. A., Hansen, L. A., Tennenbaum, T., Lichti,
U., Yee, D., LaMantia, C., Mourton, T., Herrup, K., Harris, R. C.,
Barnard, J. A., Yuspa, S. H., Coffey, R. J. and Magnuson, T. (1995).
Targeted disruption of mouse EGF receptor: effect of genetic background
on mutant phenotype. Science 269, 230-234.
Wen, D., Suggs, S. V., Karunagaran, D., Liu, N., Cupples, R. L., Luo, Y.,
Janssen, A. M., Ben-Baruch, N., Trollinger, D. B., Jacobsen, V. L., Meng,
S. -Y., Lu, H. S., Hu, S., Chang, D., Yang, W., Yanigahara, D., Koski, R.
A. and Yarden, Y. (1994). Structural and functional aspects of the the
multiplicity of neu differentiation factors. Mol. Cell. Biol. 14, 1909-1919.
Wiesen, J. F., Young, P., Werb, Z. and Cunha, G. R. (1999). Signaling
through the stromal epidermal growth factor receptor is necessary for
mammary ductal development. Development 126, 335-344.
Xie, W., Paterson, A. J., Chin, E., Nabell, L. M. and Kudlow, J. E. (1997).
Targeted expression of a dominant negative epidermal growth factor
receptor in the mammary gland of transgenic mice inhibits pubertal
mammary duct development. Mol. Endocrinol. 11, 1766-1781.
N. C. Luetteke and others
